LatinoWire

December 16, 2024 04:13 PM Eastern Time

La biotecnológica Nintx recauda USD 10 millones para desarrollar una nueva generación de medicamentos basados en la biodiversidad brasileña

Opens in new window

Download

Full Size JPEG, 1280x720, 99.7 KB
Small JPEG, 480x270, 29.2 KB
Preview JPEG, 144x81, 6.5 KB
Thumbnail JPEG, 120x68, 5.3 KB

Smart Multimedia Gallery

http://www.businesswire.com/multimedia/latinowire/20241211548548/es/5762198/

Share

Email

All News | News with Multimedia > Press Release: La biotecnológica Nintx recauda USD 10 millones...

Get Business Wire News on Your Website

Terms of Use | © 2024 Business Wire